Article info

Download PDFPDF

Protocol
Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy

Authors

  • Wenjie Long Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaLingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Huili Liao Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Xi Huang The First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Qingqing Liu The First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Yaqing Tang National Drug Clinical Trial Agency Office, Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Liming Lu Clinical Research and Data Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Jianhong Liu Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Tianhui Yuan National Drug Clinical Trial Agency Office, Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Yan Ling Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Yu Hong Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Jiao Duan Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Weiji Lin Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Shaoxiang Xian Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaLingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  • Zhongqi Yang Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaLingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaThe First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Zhongqi Yang; yang_zhongqi{at}163.com
View Full Text

Citation

Long W, Liao H, Huang X, et al
Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy

Publication history

  • Received February 26, 2020
  • Revised July 10, 2020
  • Accepted July 17, 2020
  • First published August 26, 2020.
Online issue publication 
August 26, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.